GI
CNMD icon

GAMMA Investing’s CONMED CNMD Stock Holding History

GAMMA Investing’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Sell
905
-47
-5% -$1.69K ﹤0.01% 2620
2026
Q1 		$33.7K Sell
952
-415
-30% -$16.9K ﹤0.01% 2438
2025
Q4 		$55.5K Sell
1,367
-403
-23% -$17.5K ﹤0.01% 2001
2025
Q3 		$83.2K Buy
1,770
+228
+15% +$11.8K ﹤0.01% 1636
2025
Q2 		$80.3K Buy
1,542
+225
+17% +$12.3K 0.01% 1603
2025
Q1 		$79.5K Buy
1,317
+591
+81% +$38.1K 0.01% 1445
2024
Q4 		$49.7K Buy
726
+351
+94% +$24.5K ﹤0.01% 1665
2024
Q3 		$27K Buy
375
+117
+45% +$8.26K ﹤0.01% 1925
2024
Q2 		$17.9K Buy
258
+172
+200% +$12.5K ﹤0.01% 1924
2024
Q1 		$6.89K Sell
86
-283
-77% -$25.2K ﹤0.01% 2255
2023
Q4 		$35.3K Buy
+369
New +$38.2K 0.01% 1119

Other funds holding CNMD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing's CNMD Position: Q2 2026 in Review

GAMMA Investing reduced its CONMED (CNMD) stake by 4.9% in Q2 2026, selling an estimated $1.69K and leaving 905 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

GAMMA Investing first reported a position in CNMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $83.2K in Q3 2025. 23 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • GAMMA Investing held 905 shares of CONMED worth $29.6K as of Q2 2026.
  • GAMMA Investing sold 47 CONMED shares in Q2 2026, an estimated $1.69K.
  • CONMED made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2620 holding.
  • GAMMA Investing first reported a position in CONMED in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's CONMED position peaked at $83.2K in Q3 2025.
  • 23 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.